Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals presented clinical data on TNX-102 SL for acute stress reaction and PTSD prevention, along with preclinical data on a high-throughput assay for wound healing at the 2024 Military Health System Research Symposium.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:17 am

FI

PYPL

PayPal has announced an expansion of its global strategic partnership with Fiserv. This expansion aims to simplify how Fiserv clients can enable PayPal, Venmo, and related services, providing a streamlined connection to Fastlane by PayPal to enhance guest checkout flows in the U.S.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:08 am

CMBM

Cambium Networks has announced a strategic collaboration with Quilt, Node Networks, TMA Technology Solutions, and Comed to enhance digital equity in underserved communities in Chicago. The initiative will deploy a 401-mile fiber network to increase access to affordable high-speed broadband for over 440,000 households.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:04 am

BWMN

Bowman Consulting has been contracted to start survey services for Taxiway V at Charlotte Douglas International Airport, part of the Fourth Parallel Runway Program.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:02 am

DIS

Disney's ESPN has secured broadcasting rights for the U.S. Open tennis tournament until 2037, marking its longest tennis contract. This extension aligns with ESPN's strategic shift towards streaming and highlights Disney's commitment to sports programming.

Portfolio Pulse from Benzinga Neuro

August 29, 2024 | 11:02 am

BBW

Build-A-Bear Workshop has reiterated its FY24 guidance, expecting total revenue growth in the mid-single-digit percentage range and plans to add at least 50 new experience locations.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 10:47 am

ZOM

Zomedica's Assisi Loop product line continues to be recognized as a Fear Free Preferred Product, reaffirming its effectiveness in reducing pet anxiety and pain.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 10:36 am

MRK

Merck is discontinuing two Phase 3 trials involving Keytruda due to lack of efficacy and unfavorable risk/benefit profiles. The trials, KEYNOTE-867 and KEYNOTE-630, did not meet their primary endpoints and showed higher adverse events.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 10:34 am

BYDDY

UBER

Uber CEO Dara Khosrowshahi visited BYD's headquarters in China to discuss a partnership involving the deployment of 100,000 BYD electric vehicles on Uber's platform over the next five years. The collaboration will start in Europe and Latin America and expand to other regions, with plans to integrate self-driving technologies.

Portfolio Pulse from Anan Ashraf

August 29, 2024 | 10:32 am

AAPL

NVDA

Nvidia's Q2 earnings exceeded expectations, but shares fell due to a shift in sentiment. Analyst Dan Ives compares this to Apple's post-WWDC 2024 stock performance, emphasizing the importance of demand, guidance, and growth. Nvidia's future production plans are generating strong customer anticipation.

Portfolio Pulse from Ananya Gairola

August 29, 2024 | 10:08 am